Qui sommes-nous ?
Chances are you already know us.
We are a a global leader in the field of high quality in vitro diagnostics (IVD) testing. We have more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products.
Founded in 1950 in Tokyo, Japan, Fujirebio has over the years concluded a number of successful acquisitions of best-in-class IVD companies. Examples include Centocor Diagnostics in 1998, CanAg Diagnostics in 2006 and Innogenetics in 2010. Today, our global presence includes offices in the United States, Latin America, Europe and Asia as well as a vast international distribution network.
Fujirebio is today a member of Miraca Group (Miraca Holdings Inc. listed on the Tokyo Stock Exchange – TYO: 4544) and employs more than 1.200 people in Asia, Europe and America.
For more information about Fujirebio please visit www.fujirebio.com/story.
We have a strong and long-lasting tradition of collaborating with experts in the worldwide clinical community in the development of high-quality routine and truly novel biomarkers that cover a variety of disease states. Our IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions.